» Articles » PMID: 35632610

Early and Longitudinal Humoral Response to the SARS-CoV-2 MRNA BNT162b2 Vaccine in Healthcare Workers: Significance of BMI, Adipose Tissue and Muscle Mass on Long-Lasting Post-Vaccinal Immunity

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 May 28
PMID 35632610
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to investigate the early and longitudinal humoral response in Healthcare Workers (HCWs) after two doses of the BNT162b2 vaccine and to assess the association between metabolic and anthropometric parameters and the humoral response after vaccination.

Methods: The study included 243 fully vaccinated HCWs: 25.50% previously infected with SARS-CoV-2 (with prior history of COVID-19-PH) and 74.40%-uninfected, seronegative before the first vaccination (with no prior history of COVID-19-NPH). IgG antibodies were measured, and sera were collected: prior to the vaccination, 21 days after the first dose, and 14 days and 8 months after the second dose.

Results: 21 days after the first dose, 90.95% of individuals were seropositive; 14 days after the second dose, persistent immunity was observed in 99.18% HCWs, 8 months after complete vaccination-in 61.73%. Statistical analysis revealed that HCWs with PH had a greater chance of maintaining a humoral response beyond eight months after vaccination. Increased muscle mass, decreased fat mass, and younger age may positively affect long-term immunity. Smokers have a reduced chance of developing immunity compared to non-smokers.

Conclusions: Fully vaccinated HCWs with PH are more likely to be seropositive than fully inoculated volunteers with NPH.

Citing Articles

The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review.

Gurksniene V, Alcauskas T, Majauskaite F, Jancoriene L Vaccines (Basel). 2025; 12(12.

PMID: 39772080 PMC: 11680401. DOI: 10.3390/vaccines12121419.


Does Tobacco Smoking Affect Vaccine-Induced Immune Response? A Systematic Review and Meta-Analysis.

Valeriani F, Protano C, Pozzoli A, Vitale K, Liguori F, Liguori G Vaccines (Basel). 2024; 12(11).

PMID: 39591163 PMC: 11599009. DOI: 10.3390/vaccines12111260.


BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study.

Hernandez-Bello J, Sierra-Garcia-de-Quevedo J, Morales-Nunez J, Santoscoy-Ascencio G, Diaz-Perez S, Gutierrez-Brito J Vaccines (Basel). 2023; 11(6).

PMID: 37376516 PMC: 10302149. DOI: 10.3390/vaccines11061127.


Relationship between anthropometric and body composition parameters and anti-SARS-CoV-2 specific IgG titers in females vaccinated against COVID-19 according to the heterologous vaccination course: A cohort study.

Golec M, Zembala-John J, Fronczek M, Konka A, Bochenek A, Wystyrk K PLoS One. 2023; 18(6):e0287128.

PMID: 37310975 PMC: 10263349. DOI: 10.1371/journal.pone.0287128.


Immune Response to Vaccination against COVID-19 at Different Second-Dose Intervals and Their Associations with Metabolic Parameters.

Szczerbinski L, Okruszko M, Szablowski M, Warpechowski J, Paszko A, Citko A Vaccines (Basel). 2023; 11(1).

PMID: 36679994 PMC: 9865177. DOI: 10.3390/vaccines11010149.


References
1.
Mauri C, Bosma A . Immune regulatory function of B cells. Annu Rev Immunol. 2012; 30:221-41. DOI: 10.1146/annurev-immunol-020711-074934. View

2.
Klein S, Flanagan K . Sex differences in immune responses. Nat Rev Immunol. 2016; 16(10):626-38. DOI: 10.1038/nri.2016.90. View

3.
Ferrante Jr A . The immune cells in adipose tissue. Diabetes Obes Metab. 2013; 15 Suppl 3:34-8. PMC: 3777665. DOI: 10.1111/dom.12154. View

4.
MacKenzie J, MacKenzie I, Holt P . The effect of cigarette smoking on susceptibility to epidemic influenza and on serological responses to live attenuated and killed subunit influenza vaccines. J Hyg (Lond). 1976; 77(3):409-17. PMC: 2129829. DOI: 10.1017/s0022172400055790. View

5.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View